Fabio Jung's path is unusual for a venture investor: he trained in medicine, holds a USMLE credential and an AACR Young Investigator Award, and later moved through Wharton, BCG, and investment banking before joining IKJ Capital as a Venture Partner. That medical background still shows up in his public presence today, from being quoted by CNN Brasil as a doctor and researcher on school reopening and serology during COVID to being named in connection with board discussions at Oncoclínicas, giving him a level of credibility in healthcare specifically that goes beyond typical investing experience.